The effect of 1,25-dihydroxyvitamin D, on lymphoma cell lines and expression of vitamin D receptor in lymphoma
1993

Effects of Vitamin D on Lymphoma Cells

Sample size: 13 publication Evidence: moderate

Author Information

Author(s): T. Hickishi, D. Cunningham, K. Colston, B.C. Millar, J. Sandle, A.G. Mackay, M. Soukops, J. Sloane

Primary Institution: Institute of Cancer Research, Royal Marsden Hospital

Hypothesis

The study investigates the antiproliiferative effect and differentiation induction of vitamin D3 on lymphoma cell lines and its relation to vitamin D receptor expression.

Conclusion

Vitamin D3 and its analogue MC903 can inhibit the growth of certain lymphoma cell lines and induce differentiation, but their effects occur at concentrations much higher than physiological levels.

Supporting Evidence

  • 1,25(OH)2D3 and MC903 inhibited the proliferation of SU-DHL4 and SU-DUL5 cell lines.
  • Both agents induced differentiation in the lymphoma cell lines.
  • VDR expression was low in the lymphoma cell lines and biopsy samples.

Takeaway

Vitamin D can help fight certain types of lymphoma by stopping the cancer cells from growing and helping them mature, but it needs to be used in very high amounts.

Methodology

The study evaluated the effects of 1,25(OH)2D3 and MC903 on lymphoma cell lines by measuring cell proliferation and differentiation over a period of five days.

Limitations

The study's findings may not directly translate to clinical settings due to the high concentrations of vitamin D used, which exceed physiological levels.

Participant Demographics

Patients with various categories of non-Hodgkin's lymphoma.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication